Former Pfizer VP Says All COVID “Vaccine” Manufacturers

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 energy_wave #84057
231
Former Pfizer VP Says All COVID “Vaccine” Manufacturers Need to be “Immediately Indicted for Fraud”

By Ethan Huff
Global Research,
May 27, 2022

More than 17,000 doctors and medical experts, including former Pfizer Vice President Dr. Michael Yeadon, are calling for every pharmaceutical company that makes Wuhan coronavirus (Covid-19) “vaccines” to be “immediately indicted for fraud.”

Thousands of people have died and many thousands more have become injured, in many cases permanently, from the injections, and Yeadon and his colleagues want to see justice served.

Speaking at the recent Global COVID Summit, Yeadon made the case for swift prosecution against the likes of Pfizer, BioNTech, Janssen (Johnson & Johnson), AstraZeneca, “and their enablers.” He also issued a corresponding press statement with the same claims.

For the last two years, Yeadon has been warning about the “lies” coming from Big Pharma and the government concerning Fauci Flu shots. In Principle #9 of a 10-part list of principles issued at the gathering, the following was said:

“We declare that Pfizer, Moderna, BioNTech, Janssen, AstraZeneca, and their enablers, withheld and willfully omitted safety and effectiveness information from patients and physicians, and should be immediately indicted for fraud.”

In his own words, Yeadon said the following about the death toll from the shots:

“We know that shortly after administration of these products thousands of people have died. And although correlation isn’t causation, reasonable criteria have been applied to examine the relationship between injections and the events and it is absolutely clear – cut that these [shots] are the cause of death.”

Covid “vaccines” are medical fraud

Not only did the jabs turn out to be dangerous, but Yeadon provided evidence showing that all of the jab manufacturers knew full well that this was the case before they were all unleashed by Donald Trump under Operation Warp Speed.

“The design of these products was knowingly deficient in a number of ways,” Yeadon explained, pointing to the fact that they trigger the production of “toxic virus spike protein” throughout the body.

The world was promised that these toxic virus spike proteins would remain at the injection site, but the reality is that they “distribute throughout the body,” Yeadon warned.

“There was no built-in limit to the amounts of toxic spike proteins that can be made, or for how long it is made, and that’s the cause of the toxicity,” he further stated.

With more than 30 years of experience in the industry, Yeadon is no shlock when it comes to these issues. He pointed to reports from last November showing that the clinical trials run by the likes of Pfizer involved “questionable practices all around” that point to serious fraud.

“For example, several of the studies were clearly unblinded while they were ongoing, contrary to best practice,” he explained. “And also, in a number of cases, subjects were removed from the database prior to statistical analysis in a way that is suggestive of fraud.”

“We were given blanket assurances time and again by all of the companies about the benign safety profile of their products,” he added. “Even as products rolled out in the earliest weeks, they must have known this was not true. To add insult to injury, it appears that these products provide little or no protection from the virus they sought to protect us from.”

An expert in toxicology, Yeadon further delineated that these experimental gene-based covid injections were tested using methods that were unsafe and unsound. In most cases, proper safety standards were thrown out the window entirely in order to rush the products to market at warp speed.

The U.S. Food and Drug Administration (FDA) is also complicit as it knew about the problems associated with the injections but granted them emergency use authorization (EUA) regardless.

https://www.globalresearch.ca/former-pfizer-v...ud/5781636
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
FC2 Condom Educates NYC on Health and Wellness

Updated Category News Views 9

Union Square Becomes a Hub of Interactivity The heart of NYC pulsed with purpose as FC2 Female Condom set up shop in Union Square, using the iconic location as a stage for a different kind of celebration. Clear Future, the manufacturer behind FC2, marked Global Female Condom Day with an event unlike any other. It wasn't just about the product—it was a call to educate...

Continue Reading
CSS Revamps Identity, Emphasizing Senior Living Tech

Updated Category News Views 5

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 5

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Robotics in Cleaning: 2026 Sees Double Adoption Rates

Updated Category News Views 4

Cleaning Industry Eyes Robotic Solutions Amid Labor Squeeze In a twist that's got industry veterans nodding knowingly, the cleaning industry is tipping towards automation. The recent 2026 Building Service Contractor Market Study reveals a massive leap: 32% of building service contractors (BSCs) plan to embrace robotic floor equipment in the coming year. That's a...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Rosewood HK Tops Best Hotel List Again; Asia Shines

Updated Category News Views 3

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 102

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Enphase Energy Faces Selling Pressure Amid Solar Stock Decline

Updated Category News Views 190

Enphase Energy's Recent Performance Enphase Energy Inc (NASDAQ: ENPH) has seen its shares decline sharply following the release of its quarterly results. Despite posting better than expected financial numbers, the outlook for the coming quarter has disappointed analysts. Quarterly Results Analysis In the latest quarter, Enphase Energy surprised with revenues of $363.15...

Continue Reading
Empowering Lives: Aventiv Technologies' Impact on Reentry Success

Updated Category News Views 500

Aventiv Technologies: Championing Reentry and Economic Growth Company's Fair Chance Hiring Model Exceeds Goals, While Technology Platforms Connect Incarcerated Individuals with Critical Reentry Resources Aventiv Technologies is making strides in promoting economic growth by supporting the successful reentry of incarcerated individuals. As a pioneering force in...

Continue Reading
Projected Growth of Cancer Antibody Drug Conjugates Market

Updated Category News Views 39

Understanding the Cancer Antibody Drug Conjugates Market The global landscape of cancer treatment is undergoing a transformative phase, significantly influenced by the advancement of cancer antibody drug conjugates (ADCs). These innovative therapies combine the potent cytotoxic effects of traditional chemotherapy with the targeted action of monoclonal antibodies, leading...

Continue Reading
NVIDIA's Anticipated Earnings Report: Key Insights for Investors

Updated Category News Views 145

Understanding NVIDIA's Upcoming Earnings Announcement NVIDIA (NASDAQ: NVDA) is set to release its much-anticipated quarterly earnings report soon. Investors are keen to understand how the company is performing and what guidance it will provide for future quarters. Analysts predict that NVIDIA will announce an earnings per share (EPS) of $0.98, which indicates the level of...

Continue Reading